OnDosis AB
Revolutionizing oral medicine dosing through intelligent drug/device combinations.
Yleiskatsaus
- 20–49
- Työntekijät
- 5–10milj SEK
- Liikevaihto
- 2017
- Perustettu
Avainpäättäjät
Martin Olovsson
CEO and Co-founder
Johan Öberg
Board member
Klementina Österberg
Board Member
Joshua Carney
Chief Digital Officer
+7 lisää yhteystietoja Funnelfeedrissä
Kuvaus
OnDosis is a Swedish health technology company, spun out from AstraZeneca in 2017, focused on revolutionizing how patients take oral solid medicines. They have developed a proprietary, first-in-category Dosage Manager, a handheld device that dispenses precise, individualized doses of medication in m...